More Drug Price Disclosure In Store As WHO Delegates Pass Landmark Resolution

Many see the World Health Assembly resolution on drug pricing transparency as a game changer and welcome the fact that it will shine light on an area that critics says is far too opaque. Some are unhappy that the final version is not as strong as the original draft, but industry will be relieved the WHA ultimately did not adopt a requirement for mandatory disclosure of R&D costs.

Theatre stage — A new WHA resolution is expected to throw more light on drug prices

Countries around the world are to begin sharing information on drug prices much more widely after the World Health Assembly adopted a ground-breaking resolution aimed at increasing price transparency and the affordability of medicines.

The resolution says that the WHA is “seriously concerned” about the high prices of some products and “inequitable access within...